About: Metformin induces PGC-1a expression and selectively affects hepatic PGC-1a functions     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • Background and Purpose The objective of this study was to determine how the AMPK activating antidiabetic drug metformin affects the major activator of hepatic gluconeogenesis, PPAR coactivator 1 (PGC-1) and liver functions regulated by PGC-1. Experimental Approach Mouse and human primary hepatocytes and mice in vivo were treated with metformin. Adenoviral overexpression, siRNA and reporter gene constructs were used for mechanistic studies. Key Results Metformin increased PGC-1 mRNA and protein expression in mouse primary hepatocytes. 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) (another AMPK activator) had the opposite effect. Metformin also increased PGC-1 in human primary hepatocytes; this effect of metformin was abolished by AMPK inhibitor compound C and sirtuin 1 siRNA. AMPK overexpression by AMPK-Ad also increased PGC-1. Whereas metformin increased PGC-1, it down-regulated gluconeogenic genes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase). Furthermore, metformin attenuated the increase in PEPCK and G6Pase mRNAs induced by PGC-1 overexpression, but did not affect PGC-1-mediated induction of mitochondrial genes. Metformin down-regulated several key transcription factors that mediate the effect of PGC-1 on gluconeogenic genes including Kruppel-like factor 15, forkhead box protein O1 and hepatocyte NF 4, whereas it increased nuclear respiratory factor 1, which is involved in PGC-1-mediated regulation of mitochondrial proteins. Conclusions and Implications Down-regulation of PGC-1 is not necessary for suppression of gluconeogenic genes by metformin. Importantly, metformin selectively affects hepatic PGC-1-mediated gene regulation and prevents activation of gluconeogenesis, but does not influence its regulation of mitochondrial genes. These results identify selective modulation of hepatic PGC-1 functions as a novel mechanism involved in the therapeutic action of metformin.
  • Background and Purpose The objective of this study was to determine how the AMPK activating antidiabetic drug metformin affects the major activator of hepatic gluconeogenesis, PPAR coactivator 1 (PGC-1) and liver functions regulated by PGC-1. Experimental Approach Mouse and human primary hepatocytes and mice in vivo were treated with metformin. Adenoviral overexpression, siRNA and reporter gene constructs were used for mechanistic studies. Key Results Metformin increased PGC-1 mRNA and protein expression in mouse primary hepatocytes. 5-Aminoimidazole-4-carboxamide ribonucleotide (AICAR) (another AMPK activator) had the opposite effect. Metformin also increased PGC-1 in human primary hepatocytes; this effect of metformin was abolished by AMPK inhibitor compound C and sirtuin 1 siRNA. AMPK overexpression by AMPK-Ad also increased PGC-1. Whereas metformin increased PGC-1, it down-regulated gluconeogenic genes phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase). Furthermore, metformin attenuated the increase in PEPCK and G6Pase mRNAs induced by PGC-1 overexpression, but did not affect PGC-1-mediated induction of mitochondrial genes. Metformin down-regulated several key transcription factors that mediate the effect of PGC-1 on gluconeogenic genes including Kruppel-like factor 15, forkhead box protein O1 and hepatocyte NF 4, whereas it increased nuclear respiratory factor 1, which is involved in PGC-1-mediated regulation of mitochondrial proteins. Conclusions and Implications Down-regulation of PGC-1 is not necessary for suppression of gluconeogenic genes by metformin. Importantly, metformin selectively affects hepatic PGC-1-mediated gene regulation and prevents activation of gluconeogenesis, but does not influence its regulation of mitochondrial genes. These results identify selective modulation of hepatic PGC-1 functions as a novel mechanism involved in the therapeutic action of metformin. (en)
Title
  • Metformin induces PGC-1a expression and selectively affects hepatic PGC-1a functions
  • Metformin induces PGC-1a expression and selectively affects hepatic PGC-1a functions (en)
skos:prefLabel
  • Metformin induces PGC-1a expression and selectively affects hepatic PGC-1a functions
  • Metformin induces PGC-1a expression and selectively affects hepatic PGC-1a functions (en)
skos:notation
  • RIV/00216208:11160/14:10282278!RIV15-MSM-11160___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, P(GAP303/12/0472)
http://linked.open...iv/cisloPeriodika
  • 9
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 28602
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11160/14:10282278
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • G6Pase; PEPCK; SIRT1; liver; gluconeogenesis; metformin; AMPK; PGC-1 (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV
  • [230712AC3D2E]
http://linked.open...i/riv/nazevZdroje
  • British Journal of Pharmacology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...vavai/riv/projekt
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 171
http://linked.open...iv/tvurceVysledku
  • Pávek, Petr
  • Aatsinki, Sanna-Mari
  • Buler, Marcin
  • Hakkola, Jukka
  • Koulu, Markku
  • Salomaki, Henriikka
http://linked.open...ain/vavai/riv/wos
  • 000334156100008
issn
  • 0007-1188
number of pages
http://bibframe.org/vocab/doi
  • 10.1111/bph.12585
http://localhost/t...ganizacniJednotka
  • 11160
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 77 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software